08-Dec-15

PhD, Masters or Honours

The precise neurobiological mechanisms underlying ADHD are poorly understood and may differ between individuals. There is a need to identify subtypes of ADHD with similar pathophysiology, and to identify biological markers that allow for a more personalised treatment approach. This project will use psychophysiological measures (e.g. electroencephalogram, skin conductance, heart rate) to compare children and adolescents who have responded well to a stimulant (methylphenidate) or a non-stimulant (atomoxetine) medication in a clinical trial.  With this project we aim to improve the understanding of the neurobiological mechanisms underlying ADHD and  to identify non-invasive psychophysiological markers for guiding individualised treatment decisions.

Supervisors: Assoc Prof Michael Kohn, Michael.kohn@health.nsw.gov.au and Dr Kristi Griffiths, Kristi.griffiths@sydney.edu.au